NYSE:DOCS 6 December 2025

Doximity shares fell over 10% to close at $45.93 on December 5, 2025, hitting a new 52-week low despite reporting Q2 revenue of $168–169 million and non-GAAP EPS of $0.45, both above estimates. The stock now trades about 46% below its February high. Management raised full-year revenue guidance, while analysts maintain a consensus “Buy” rating with an average target near $68.